| Product Code: ETC7644914 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s import of antimicrobial peptides in 2024 saw top suppliers including Switzerland, USA, Germany, China, and Belgium, indicating a diverse sourcing strategy. Despite a high Herfindahl-Hirschman Index (HHI) reflecting market concentration, the industry experienced a negative compound annual growth rate (CAGR) of -13.88% from 2020 to 2024. However, there was a positive growth rate of 8.63% from 2023 to 2024, suggesting a potential rebound in demand and market expansion in the antimicrobial peptides sector in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antimicrobial Peptides Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antimicrobial Peptides Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antimicrobial Peptides Market - Industry Life Cycle |
3.4 Israel Antimicrobial Peptides Market - Porter's Five Forces |
3.5 Israel Antimicrobial Peptides Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Antimicrobial Peptides Market Revenues & Volume Share, By Ailments, 2021 & 2031F |
3.7 Israel Antimicrobial Peptides Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Israel Antimicrobial Peptides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Antimicrobial Peptides Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Israel Antimicrobial Peptides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections |
4.2.2 Growing awareness about the benefits of antimicrobial peptides |
4.2.3 Rising demand for alternatives to antibiotics in healthcare and agriculture |
4.3 Market Restraints |
4.3.1 High production costs of antimicrobial peptides |
4.3.2 Regulatory challenges in approval and commercialization of antimicrobial peptides |
5 Israel Antimicrobial Peptides Market Trends |
6 Israel Antimicrobial Peptides Market, By Types |
6.1 Israel Antimicrobial Peptides Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Antimicrobial Peptides Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Antimicrobial Peptides Market Revenues & Volume, By Plant Antimicrobial Peptides, 2021- 2031F |
6.1.4 Israel Antimicrobial Peptides Market Revenues & Volume, By Bacterial Antimicrobial Peptides, 2021- 2031F |
6.1.5 Israel Antimicrobial Peptides Market Revenues & Volume, By Animal Antimicrobial Peptides, 2021- 2031F |
6.1.6 Israel Antimicrobial Peptides Market Revenues & Volume, By Insect Antimicrobial Peptides, 2021- 2031F |
6.2 Israel Antimicrobial Peptides Market, By Ailments |
6.2.1 Overview and Analysis |
6.2.2 Israel Antimicrobial Peptides Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.2.3 Israel Antimicrobial Peptides Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.4 Israel Antimicrobial Peptides Market Revenues & Volume, By Bacterial infections, 2021- 2031F |
6.2.5 Israel Antimicrobial Peptides Market Revenues & Volume, By HIV, 2021- 2031F |
6.3 Israel Antimicrobial Peptides Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Antimicrobial Peptides Market Revenues & Volume, By Hospital, 2021- 2031F |
6.3.3 Israel Antimicrobial Peptides Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.4 Israel Antimicrobial Peptides Market Revenues & Volume, By Specialty Clinic, 2021- 2031F |
6.3.5 Israel Antimicrobial Peptides Market Revenues & Volume, By Pharmacies, 2021- 2031F |
6.4 Israel Antimicrobial Peptides Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Antimicrobial Peptides Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.3 Israel Antimicrobial Peptides Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 Israel Antimicrobial Peptides Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.5 Israel Antimicrobial Peptides Market, By End-user |
6.5.1 Overview and Analysis |
6.5.2 Israel Antimicrobial Peptides Market Revenues & Volume, By Pharma and Healthcare, 2021- 2031F |
6.5.3 Israel Antimicrobial Peptides Market Revenues & Volume, By Agriculture Industry, 2021- 2031F |
6.5.4 Israel Antimicrobial Peptides Market Revenues & Volume, By Biological Engineering, 2021- 2031F |
7 Israel Antimicrobial Peptides Market Import-Export Trade Statistics |
7.1 Israel Antimicrobial Peptides Market Export to Major Countries |
7.2 Israel Antimicrobial Peptides Market Imports from Major Countries |
8 Israel Antimicrobial Peptides Market Key Performance Indicators |
8.1 Research and development investment in antimicrobial peptides |
8.2 Number of partnerships and collaborations for antimicrobial peptide development |
8.3 Number of patents related to new antimicrobial peptides |
8.4 Clinical trial success rates for antimicrobial peptides |
8.5 Adoption rate of antimicrobial peptides in healthcare and agriculture industries |
9 Israel Antimicrobial Peptides Market - Opportunity Assessment |
9.1 Israel Antimicrobial Peptides Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Antimicrobial Peptides Market Opportunity Assessment, By Ailments, 2021 & 2031F |
9.3 Israel Antimicrobial Peptides Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Israel Antimicrobial Peptides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Antimicrobial Peptides Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Israel Antimicrobial Peptides Market - Competitive Landscape |
10.1 Israel Antimicrobial Peptides Market Revenue Share, By Companies, 2024 |
10.2 Israel Antimicrobial Peptides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here